Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Feinberg

Showing results (51-60 of 161) with videos related to

Pageof 17
Sort By:
Open Forum Infectious Diseases|April 14, 2020
<i>Brucella</i> Endocarditis in Persons Who Inject DrugsJohn M Cafardi, Douglas Haas, Thomas Lamarre, et al.
Journal of Human Behavior in the Social Environment|September 26, 2019
The Impact of Rural Classification Systems on a Comparison of Risky Drug-Related Behaviors in Kentucky and Ohio CountiesAmanda N Stover, Erin L Winstanley, Yifan Zhang, et al.
Substance Abuse|December 20, 2015
Barriers to implementation of opioid overdose prevention programs in OhioErin L Winstanley, Angela Clark, Judith Feinberg, et al.
American Journal of Preventive Medicine|October 5, 2020
Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West VirginiaStacy Tressler, Christa Lilly, Diane Gross, et al.
Current HIV/AIDS Reports|May 19, 2018
Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?Katherine M Rich, Joshua Bia, Frederick L Altice, et al.
Annals of Internal Medicine|July 7, 2020
Tenofovir Alafenamide for HIV Preexposure ProphylaxisDouglas S Krakower, Demetre C Daskalakis, Judith Feinberg, et al.
Annals of Internal Medicine|January 14, 2020
Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value?Douglas S Krakower, Demetre C Daskalakis, Judith Feinberg, et al.
Drug and Alcohol Dependence|June 26, 2025
Longitudinal patterns of opioid and stimulant use by route of administration among people who inject drugs in the South Atlantic Fentanyl Test Strip Study: A latent transition analysisNicholas Peiper, Arnie Aldridge, Stephen Tueller, et al.
Substance Use & Misuse|December 22, 2022
Factors Associated with Non-Evidence-Based Overdose Responses among People Who Use Prescription Opioids Non-Medically in Rural AppalachiaAlexandria Macmadu, Kelly K Gurka, Herbert I Linn, et al.
Antiviral Therapy|April 26, 2003
Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-upRichard N Greenberg, Judith Feinberg, James Goodrich, et al.
Pageof 17

Showing results (51-60 of 161) with videos related to

Sort By:
Pageof 17
Open Forum Infectious Diseases|April 14, 2020
<i>Brucella</i> Endocarditis in Persons Who Inject DrugsJohn M Cafardi, Douglas Haas, Thomas Lamarre, et al.
Journal of Human Behavior in the Social Environment|September 26, 2019
The Impact of Rural Classification Systems on a Comparison of Risky Drug-Related Behaviors in Kentucky and Ohio CountiesAmanda N Stover, Erin L Winstanley, Yifan Zhang, et al.
Substance Abuse|December 20, 2015
Barriers to implementation of opioid overdose prevention programs in OhioErin L Winstanley, Angela Clark, Judith Feinberg, et al.
American Journal of Preventive Medicine|October 5, 2020
Variations in Hepatitis B Vaccine Series Completion by Setting Among Adults at Risk in West VirginiaStacy Tressler, Christa Lilly, Diane Gross, et al.
Current HIV/AIDS Reports|May 19, 2018
Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?Katherine M Rich, Joshua Bia, Frederick L Altice, et al.
Annals of Internal Medicine|July 7, 2020
Tenofovir Alafenamide for HIV Preexposure ProphylaxisDouglas S Krakower, Demetre C Daskalakis, Judith Feinberg, et al.
Annals of Internal Medicine|January 14, 2020
Tenofovir Alafenamide for HIV Preexposure Prophylaxis: What Can We DISCOVER About Its True Value?Douglas S Krakower, Demetre C Daskalakis, Judith Feinberg, et al.
Drug and Alcohol Dependence|June 26, 2025
Longitudinal patterns of opioid and stimulant use by route of administration among people who inject drugs in the South Atlantic Fentanyl Test Strip Study: A latent transition analysisNicholas Peiper, Arnie Aldridge, Stephen Tueller, et al.
Substance Use & Misuse|December 22, 2022
Factors Associated with Non-Evidence-Based Overdose Responses among People Who Use Prescription Opioids Non-Medically in Rural AppalachiaAlexandria Macmadu, Kelly K Gurka, Herbert I Linn, et al.
Antiviral Therapy|April 26, 2003
Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-upRichard N Greenberg, Judith Feinberg, James Goodrich, et al.
Pageof 17